XML 67 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Fair Value Measurement
3 Months Ended
Mar. 31, 2015
Disclosure Text Block [Abstract]  
Fair Value, Option [Text Block]

10. Fair Value Measurement. Fair value is defined as the price that would be received on the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs of valuation techniques used to measure fair value of nonfinancial assets and liabilities. The inputs are evaluated and an overall level for the fair value measurement is determined. This overall level is an indication of the market observability of the fair value measurement. In order to determine the fair value, the Bank must determine the unit of account, highest and best use, principal market, and market participants. These determinations allow the Bank to define the inputs for fair value and level of hierarchy. The Bank groups financial assets at fair value in the three levels listed below based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.


Level 1: inputs to the valuation methodology are quoted prices in active markets for identical assets or liabilities that the Bank has the ability to access at the measurement date. A quoted price in an active market provides the most reliable evidence of fair value and shall be used to measure fair value whenever available. The types of assets carried at Level 1 fair value generally include investments such as U. S. Treasury and U. S. government agency securities.


Level 2: inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets and price quotations can vary substantially either over time or among market makers. The types of assets carried at Level 2 fair value generally include mortgage-backed securities issued by Government Sponsored Enterprises (“GSEs”), municipal bonds, corporate debt securities, mortgage loans held for sale and bank-owned life insurance.


Level 3: inputs to the valuation methodology are unobservable to the extent that observable inputs are not available. Unobservable inputs are developed based on the best information available in the circumstances and might include the Bank’s own assumptions. The Bank shall not ignore information about market participant assumptions that is reasonably available without undue cost and effort. The types of assets carried at Level 3 fair value generally include investments backed by non-traditional mortgage loans or certain state or local housing agency obligations, of which the Bank has no such assets or liabilities. Level 3 also includes impaired loans and other real estate owned.


The following table presents assets measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014:


   

Fair Value

   

Quoted Prices In

Active Markets for

Identical Assets

   

Significant

Observable

Inputs-Other

   

Significant Unobservable

Inputs

 
   

(In thousands)

 

Description

 

3/31/15

   

Level 1

   

Level 2

   

Level 3

 

Securities available for sale:

                               

Government securities

  $ 31,659     $ 31,659     $ -     $ -  

Mortgage-backed securities

    156,089       -       156,089       -  

Municipal securities

    55,921       -       55,921       -  

Corporate bonds

    28,814       -       28,814       -  

Mortgage loans held for sale

    7,947       -       7,947       -  

Bank-owned life insurance

    15,252       -       15,252       -  

Interest rate swap

    (509 )     -       (509 )     -  

Total March 31, 2015

  $ 295,173     $ 31,659     $ 263,514     $ -  

Description

 

12/31/14

   

Level 1

   

Level 2

   

Level 3

 

Securities available for sale:

                               

Government securities

  $ 31,232     $ 31,232     $ -     $ -  

Mortgage-backed securities

    174,280       -       174,280       -  

Municipal securities

    55,702       -       55,702       -  

Corporate bonds

    31,085       -       31,085       -  

Mortgage loans held for sale

    4,793       -       4,793       -  

Bank-owned life insurance

    15,125       -       15,125       -  

Interest rate swap

    (405 )     -       (405 )     -  

Total December 31, 2014

  $ 311,812     $ 31,232     $ 280,580     $ -  

The following table presents assets measured at fair value on a non-recurring basis as of March 31, 2015 and December 31, 2014:


   

Fair Value

   

Quoted Prices In Active Markets for Identical Assets

   

Significant

Observable

Inputs-Other

   

Significant Unobservable

Inputs

 
   

(In thousands)

 

Description

 

3/31/15

   

Level 1

   

Level 2

   

Level 3

 

Impaired loans, net

  $ 18,384     $ -     $ -     $ 18,384  

Other real estate owned

    7,082       -       -       7,082  

Total March 31, 2015

  $ 25,466     $ -     $ -     $ 25,466  

Description

 

12/31/14

   

Level 1

   

Level 2

   

Level 3

 

Impaired loans, net

  $ 19,480     $ -     $ -     $ 19,480  

Other real estate owned

    7,756       -       -       7,756  

Total December 31, 2014

  $ 27,236     $ -     $ -     $ 27,236  

Impaired loans at March 31, 2015 and December 31, 2014 includes $16.4 million and $17.3 million, respectively, of loans identified as impaired, even though an impairment analysis calculated pursuant to ASC 310-10-35 resulted in no allowance.


Quoted market price for similar assets in active markets is the valuation technique for determining fair value of securities available for sale and held to maturity. Unrealized gains on available for sale securities are included in the “accumulated other comprehensive income” component of the Stockholders’ Equity section of the Consolidated Statements of Financial Condition. The estimated fair value of loans held for sale is based on commitments from investors within the secondary market for loans with similar characteristics.


The Company does not record loans held for investment at fair value on a recurring basis. However, when a loan is considered impaired an impairment write down is taken based on the loan’s estimated fair value. The fair value of impaired loans is estimated using one of several methods, including collateral value, market value of similar debt, enterprise value, liquidation value and discounted cash flows. Those loans not requiring a write down represent loans for which the fair value of the expected repayments or collateral exceed the recorded investments in such loans, and are not included above.


Impaired loans where a write down is taken based on fair value of collateral require classification in the fair value hierarchy. When the fair value of the collateral is based on an observable market price or a current appraised value, the Company records the impaired loan as non-recurring Level 2. When an appraised value is not available or management determines the fair value of the collateral is further impaired below the appraised value and there is no observable market price, the Company classifies the impaired loan as non-recurring Level 3.


OREO is recorded at fair value upon transfer of the loans to foreclosed assets, based on the appraised market value of the property. OREO is reviewed quarterly and values are adjusted as determined appropriate. Fair value is based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. When an appraised value is not available or management determines the fair value of the collateral is impaired below the appraised value and there is no observable market price, the Company classifies the foreclosed asset as non-recurring Level 3. Fair value adjustments of $44,228 were made to OREO during the three months ended March 31, 2015, compared to $11,200 made during the three months ended March 31, 2014.


Net gains realized on sales of OREO and included in earnings for the three months ended March 31, 2015 and 2014 are reported in other revenues as follows:


   

Three Months Ended 3/31/15

   

Three Months Ended 3/31/14

 

Net gains on sales of OREO

  $ 45,867     $ 39,420  

No liabilities were measured at fair value on a recurring or non-recurring basis at March 31, 2015 or December 31, 2014.